Proton pump inhibitors and vascular function: A prospective cross-over pilot study - Wikidata - wikimedia - TriplyDB

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

http://www.wikidata.org/entity/Q36067712

about

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.How May Proton Pump Inhibitors Impair Cardiovascular Health?Proton Pump Inhibitors Accelerate Endothelial Senescence Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.Proton-pump inhibitors: understanding the complications and risks.Can Endothelial Injury Provide the Passage to Explain the Vascular Effects of Proton Pump Inhibitors?Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment.Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.

P2860

Q26741015-6F27636C-1548-4950-9FA3-EB507605CC1D Q31157434-AE9C9DAA-99DB-413F-98B7-9CF9F93E24A1 Q36117874-737EC3A6-FB3B-4E39-BC0C-BDA0D9C098CA Q36846899-55DBD7A4-4C74-44D7-B18E-4632F216D176 Q36892867-2B138099-5850-4A83-9B50-E07B1E30A349 Q36993998-6E003B2B-A89D-45F1-8771-96C736BE34BB Q37171592-B780F2E2-4099-4BA9-980B-9A347B666535 Q37607150-1E5001DE-16E5-4CCC-8884-F1EB2F9647B8 Q40248473-E749FB09-E208-495F-95A5-E40BF295F0BA Q41996131-1014A257-DA73-4E8C-BA12-36E2DA45EB6B Q42333495-8EE723B0-4FA9-43C1-B640-9E145D182307 Q42371575-1022A2E8-D27E-4C3E-8F39-526CB91E9A61 Q48105004-4D429B46-3F15-4949-8725-7BCC05D967FF Q48200162-BDEC9E55-E443-4EAC-8514-B7C00E0B82BC

P2860

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

http://www.wikidata.org/entity/Q36067712

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@ast

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@en

type

label

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@ast

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@en

prefLabel

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@ast

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@en

P1433

Q36067712-5A8CAC9B-851B-4450-9EE7-A55B0DEBA9DD

P1476

Q36067712-BB1A13FD-18B6-4813-8366-DA02F08CB2CA

P2093

Q36067712-0456015E-86CC-4893-8EF2-65B4AF850870

Q36067712-431039E1-9F02-4FDB-8CB1-527B91FC29FA

Q36067712-5629ECE4-4481-4065-81BB-30C59B073004

Q36067712-5863B2EE-969A-4520-95D2-E42770D72ECA

Q36067712-5C500EAA-8DE1-43B8-9A85-4361391EBE72

Q36067712-9ECB69BB-8F28-433D-B7DA-4810DD14DE27

Q36067712-A5499948-D869-4362-B079-8D51CDA2FA83

P2860

Q36067712-02869C23-D471-4ED2-AAD7-2B2FB9F7EB9D

Q36067712-10AB2941-DCC2-4EB2-9829-EFA90165AE4A

Q36067712-1259265D-409D-43B5-9195-7E20EEA393D0

Q36067712-1992FD0B-E092-4D30-8FE8-3B7C41FDB2FE

Q36067712-1FA7BE33-8010-4B26-85CA-DA421FBD6B84

Q36067712-226EA250-9F36-4185-9A94-8C16D090C6E9

Q36067712-2725ECFE-4699-434F-9D5E-FC27BF55DE9C

Q36067712-2855AB11-1AD1-47DA-AA4F-53D82283E495

Q36067712-2F45DE07-7CF2-4FCD-AA6A-CFA69B32AA40

Q36067712-31D51FA5-C3DC-40F3-BCD8-41DF3C6ECCC0

P304

Q36067712-B9D0AA6F-CE48-4923-8D58-06F93D448667

P31

Q36067712-6346CCBC-B1DC-451C-96D9-06226B35F65F

P356

Q36067712-F246BE42-ECF7-44FF-9DD5-C428DFD8C0C1

P433

Q36067712-73A2FA24-14E0-49C5-900B-0779B85E2EFA

P478

Q36067712-7D64A041-8188-4C8B-BBC3-020B953044F8

P50

Q36067712-DC93AD1D-6A96-4E23-8E5A-E032FFCED671

P577

Q36067712-1978CC71-C9B7-43A6-8288-FCB4AD4312F7

P698

Q36067712-509DD0DE-58C3-4740-B263-5D4AABBDBBD8

P932

Q36067712-A4E17616-B0FE-4E48-92CF-17BC340D6733

P356

1358863X14568444

P1433

Vascular Medicine

P1476

Proton pump inhibitors and vascular function: A prospective cross-over pilot study

@en

P2093

Fouzia Khan

http://www.w3.org/2001/XMLSchema#string

Kevin T Nead

http://www.w3.org/2001/XMLSchema#string

Nicholas J Leeper

http://www.w3.org/2001/XMLSchema#string

Nigam H Shah

http://www.w3.org/2001/XMLSchema#string

Peter Chang

http://www.w3.org/2001/XMLSchema#string

Rahul N Thakker

http://www.w3.org/2001/XMLSchema#string

Yohannes T Ghebremariam

http://www.w3.org/2001/XMLSchema#string

P2860

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Endothelial dysfunction as a target for prevention of cardiovascular disease.

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Pharmacological management of GERD: where does it stand now?

Asymmetrical dimethylarginine: the Uber marker?

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

P304

309-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1358863X14568444

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25835348

http://www.w3.org/2001/XMLSchema#string

P932

4572842

http://www.w3.org/2001/XMLSchema#string